Disease | aplastic anemia |
Symptom | C0021079|immunosuppression |
Sentences | 2 |
PubMedID- 26261674 | aplastic anemia (aa) patients with prolonged immunosuppression have a risk of development of lymphoproliferative disorders (lpds), especially combined with epstein-barr virus (ebv) infection. |
PubMedID- 23049358 | The myelodysplastic syndromes (mds), acute myeloid leukemias (aml) and secondary myeloproliferative syndromes (mps) constitute a group of myeloid neoplasias (mns) which result from exposure to risk factors such as chemotherapy and radiotherapy, acquired aplastic anemia associated with immunosuppression and congenital diseases. |
Page: 1